These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The use of newer progestins for contraception. Sitruk-Ware R, Nath A. Contraception; 2010 Nov 10; 82(5):410-7. PubMed ID: 20933114 [Abstract] [Full Text] [Related]
17. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH. Contraception; 1996 Oct 10; 54(4):243-51. PubMed ID: 8922878 [Abstract] [Full Text] [Related]
18. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits. Sitruk-Ware R. Menopause; 2002 Oct 10; 9(1):6-15. PubMed ID: 11791081 [Abstract] [Full Text] [Related]
19. A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor. Louw-du Toit R, Hapgood JP, Africander D. Biochem Biophys Res Commun; 2020 May 28; 526(2):466-471. PubMed ID: 32234237 [Abstract] [Full Text] [Related]
20. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity. Phillips A, Hahn DW, McGuire JL. Am J Obstet Gynecol; 1992 Oct 28; 167(4 Pt 2):1191-6. PubMed ID: 1415445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]